Request for Covid-19 Impact Assessment of this Report
The United States Pertussis Vaccination market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Pertussis Vaccination market, reaching US$ million by the year 2028. As for the Europe Pertussis Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Pertussis Vaccination players cover Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, and KM Biologics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Vaccination market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Acellular Vaccines
Whole-cell Vaccines
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
12 Months Below
12 Months Above
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pertussis Vaccination Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pertussis Vaccination by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pertussis Vaccination by Country/Region, 2017, 2022 & 2028
2.2 Pertussis Vaccination Segment by Type
2.2.1 Acellular Vaccines
2.2.2 Whole-cell Vaccines
2.3 Pertussis Vaccination Sales by Type
2.3.1 Global Pertussis Vaccination Sales Market Share by Type (2017-2022)
2.3.2 Global Pertussis Vaccination Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pertussis Vaccination Sale Price by Type (2017-2022)
2.4 Pertussis Vaccination Segment by Application
2.4.1 12 Months Below
2.4.2 12 Months Above
2.5 Pertussis Vaccination Sales by Application
2.5.1 Global Pertussis Vaccination Sale Market Share by Application (2017-2022)
2.5.2 Global Pertussis Vaccination Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pertussis Vaccination Sale Price by Application (2017-2022)
3 Global Pertussis Vaccination by Company
3.1 Global Pertussis Vaccination Breakdown Data by Company
3.1.1 Global Pertussis Vaccination Annual Sales by Company (2020-2022)
3.1.2 Global Pertussis Vaccination Sales Market Share by Company (2020-2022)
3.2 Global Pertussis Vaccination Annual Revenue by Company (2020-2022)
3.2.1 Global Pertussis Vaccination Revenue by Company (2020-2022)
3.2.2 Global Pertussis Vaccination Revenue Market Share by Company (2020-2022)
3.3 Global Pertussis Vaccination Sale Price by Company
3.4 Key Manufacturers Pertussis Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pertussis Vaccination Product Location Distribution
3.4.2 Players Pertussis Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pertussis Vaccination by Geographic Region
4.1 World Historic Pertussis Vaccination Market Size by Geographic Region (2017-2022)
4.1.1 Global Pertussis Vaccination Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pertussis Vaccination Annual Revenue by Geographic Region
4.2 World Historic Pertussis Vaccination Market Size by Country/Region (2017-2022)
4.2.1 Global Pertussis Vaccination Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pertussis Vaccination Annual Revenue by Country/Region
4.3 Americas Pertussis Vaccination Sales Growth
4.4 APAC Pertussis Vaccination Sales Growth
4.5 Europe Pertussis Vaccination Sales Growth
4.6 Middle East & Africa Pertussis Vaccination Sales Growth
5 Americas
5.1 Americas Pertussis Vaccination Sales by Country
5.1.1 Americas Pertussis Vaccination Sales by Country (2017-2022)
5.1.2 Americas Pertussis Vaccination Revenue by Country (2017-2022)
5.2 Americas Pertussis Vaccination Sales by Type
5.3 Americas Pertussis Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pertussis Vaccination Sales by Region
6.1.1 APAC Pertussis Vaccination Sales by Region (2017-2022)
6.1.2 APAC Pertussis Vaccination Revenue by Region (2017-2022)
6.2 APAC Pertussis Vaccination Sales by Type
6.3 APAC Pertussis Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pertussis Vaccination by Country
7.1.1 Europe Pertussis Vaccination Sales by Country (2017-2022)
7.1.2 Europe Pertussis Vaccination Revenue by Country (2017-2022)
7.2 Europe Pertussis Vaccination Sales by Type
7.3 Europe Pertussis Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pertussis Vaccination by Country
8.1.1 Middle East & Africa Pertussis Vaccination Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pertussis Vaccination Revenue by Country (2017-2022)
8.2 Middle East & Africa Pertussis Vaccination Sales by Type
8.3 Middle East & Africa Pertussis Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pertussis Vaccination
10.3 Manufacturing Process Analysis of Pertussis Vaccination
10.4 Industry Chain Structure of Pertussis Vaccination
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pertussis Vaccination Distributors
11.3 Pertussis Vaccination Customer
12 World Forecast Review for Pertussis Vaccination by Geographic Region
12.1 Global Pertussis Vaccination Market Size Forecast by Region
12.1.1 Global Pertussis Vaccination Forecast by Region (2023-2028)
12.1.2 Global Pertussis Vaccination Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pertussis Vaccination Forecast by Type
12.7 Global Pertussis Vaccination Forecast by Application
13 Key Players Analysis
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Pertussis Vaccination Product Offered
13.1.3 Sanofi Pasteur Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pertussis Vaccination Product Offered
13.2.3 GSK Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Mitsubishi Tanabe Pharma
13.3.1 Mitsubishi Tanabe Pharma Company Information
13.3.2 Mitsubishi Tanabe Pharma Pertussis Vaccination Product Offered
13.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 KM Biologics
13.4.1 KM Biologics Company Information
13.4.2 KM Biologics Pertussis Vaccination Product Offered
13.4.3 KM Biologics Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 KM Biologics Main Business Overview
13.4.5 KM Biologics Latest Developments
13.5 Wuhan Institute of Biological Products
13.5.1 Wuhan Institute of Biological Products Company Information
13.5.2 Wuhan Institute of Biological Products Pertussis Vaccination Product Offered
13.5.3 Wuhan Institute of Biological Products Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Wuhan Institute of Biological Products Main Business Overview
13.5.5 Wuhan Institute of Biological Products Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology Pertussis Vaccination Product Offered
13.6.3 Walvax Biotechnology Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Chengdu Institute of Biological Products
13.7.1 Chengdu Institute of Biological Products Company Information
13.7.2 Chengdu Institute of Biological Products Pertussis Vaccination Product Offered
13.7.3 Chengdu Institute of Biological Products Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Chengdu Institute of Biological Products Main Business Overview
13.7.5 Chengdu Institute of Biological Products Latest Developments
13.8 Minhai Biotechnology
13.8.1 Minhai Biotechnology Company Information
13.8.2 Minhai Biotechnology Pertussis Vaccination Product Offered
13.8.3 Minhai Biotechnology Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Minhai Biotechnology Main Business Overview
13.8.5 Minhai Biotechnology Latest Developments
14 Research Findings and Conclusion
Table 1. Pertussis Vaccination Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pertussis Vaccination Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Acellular Vaccines
Table 4. Major Players of Whole-cell Vaccines
Table 5. Global Pertussis Vaccination Sales by Type (2017-2022) & (Units)
Table 6. Global Pertussis Vaccination Sales Market Share by Type (2017-2022)
Table 7. Global Pertussis Vaccination Revenue by Type (2017-2022) & ($ million)
Table 8. Global Pertussis Vaccination Revenue Market Share by Type (2017-2022)
Table 9. Global Pertussis Vaccination Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Pertussis Vaccination Sales by Application (2017-2022) & (Units)
Table 11. Global Pertussis Vaccination Sales Market Share by Application (2017-2022)
Table 12. Global Pertussis Vaccination Revenue by Application (2017-2022)
Table 13. Global Pertussis Vaccination Revenue Market Share by Application (2017-2022)
Table 14. Global Pertussis Vaccination Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Pertussis Vaccination Sales by Company (2020-2022) & (Units)
Table 16. Global Pertussis Vaccination Sales Market Share by Company (2020-2022)
Table 17. Global Pertussis Vaccination Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Pertussis Vaccination Revenue Market Share by Company (2020-2022)
Table 19. Global Pertussis Vaccination Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Pertussis Vaccination Producing Area Distribution and Sales Area
Table 21. Players Pertussis Vaccination Products Offered
Table 22. Pertussis Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pertussis Vaccination Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Pertussis Vaccination Sales Market Share Geographic Region (2017-2022)
Table 27. Global Pertussis Vaccination Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Pertussis Vaccination Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Pertussis Vaccination Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Pertussis Vaccination Sales Market Share by Country/Region (2017-2022)
Table 31. Global Pertussis Vaccination Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Pertussis Vaccination Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Pertussis Vaccination Sales by Country (2017-2022) & (Units)
Table 34. Americas Pertussis Vaccination Sales Market Share by Country (2017-2022)
Table 35. Americas Pertussis Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Pertussis Vaccination Revenue Market Share by Country (2017-2022)
Table 37. Americas Pertussis Vaccination Sales by Type (2017-2022) & (Units)
Table 38. Americas Pertussis Vaccination Sales Market Share by Type (2017-2022)
Table 39. Americas Pertussis Vaccination Sales by Application (2017-2022) & (Units)
Table 40. Americas Pertussis Vaccination Sales Market Share by Application (2017-2022)
Table 41. APAC Pertussis Vaccination Sales by Region (2017-2022) & (Units)
Table 42. APAC Pertussis Vaccination Sales Market Share by Region (2017-2022)
Table 43. APAC Pertussis Vaccination Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Pertussis Vaccination Revenue Market Share by Region (2017-2022)
Table 45. APAC Pertussis Vaccination Sales by Type (2017-2022) & (Units)
Table 46. APAC Pertussis Vaccination Sales Market Share by Type (2017-2022)
Table 47. APAC Pertussis Vaccination Sales by Application (2017-2022) & (Units)
Table 48. APAC Pertussis Vaccination Sales Market Share by Application (2017-2022)
Table 49. Europe Pertussis Vaccination Sales by Country (2017-2022) & (Units)
Table 50. Europe Pertussis Vaccination Sales Market Share by Country (2017-2022)
Table 51. Europe Pertussis Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Pertussis Vaccination Revenue Market Share by Country (2017-2022)
Table 53. Europe Pertussis Vaccination Sales by Type (2017-2022) & (Units)
Table 54. Europe Pertussis Vaccination Sales Market Share by Type (2017-2022)
Table 55. Europe Pertussis Vaccination Sales by Application (2017-2022) & (Units)
Table 56. Europe Pertussis Vaccination Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Pertussis Vaccination Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Pertussis Vaccination Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Pertussis Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Pertussis Vaccination Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pertussis Vaccination Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Pertussis Vaccination Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Pertussis Vaccination Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Pertussis Vaccination Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Pertussis Vaccination
Table 66. Key Market Challenges & Risks of Pertussis Vaccination
Table 67. Key Industry Trends of Pertussis Vaccination
Table 68. Pertussis Vaccination Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Pertussis Vaccination Distributors List
Table 71. Pertussis Vaccination Customer List
Table 72. Global Pertussis Vaccination Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Pertussis Vaccination Sales Market Forecast by Region
Table 74. Global Pertussis Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Pertussis Vaccination Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Pertussis Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Pertussis Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Pertussis Vaccination Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Pertussis Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Pertussis Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Pertussis Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Pertussis Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Pertussis Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Pertussis Vaccination Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Pertussis Vaccination Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Pertussis Vaccination Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Pertussis Vaccination Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Pertussis Vaccination Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Pertussis Vaccination Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Pertussis Vaccination Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Pertussis Vaccination Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Pasteur Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Pasteur Pertussis Vaccination Product Offered
Table 94. Sanofi Pasteur Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Sanofi Pasteur Main Business
Table 96. Sanofi Pasteur Latest Developments
Table 97. GSK Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Pertussis Vaccination Product Offered
Table 99. GSK Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. Mitsubishi Tanabe Pharma Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 103. Mitsubishi Tanabe Pharma Pertussis Vaccination Product Offered
Table 104. Mitsubishi Tanabe Pharma Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Mitsubishi Tanabe Pharma Main Business
Table 106. Mitsubishi Tanabe Pharma Latest Developments
Table 107. KM Biologics Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 108. KM Biologics Pertussis Vaccination Product Offered
Table 109. KM Biologics Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. KM Biologics Main Business
Table 111. KM Biologics Latest Developments
Table 112. Wuhan Institute of Biological Products Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 113. Wuhan Institute of Biological Products Pertussis Vaccination Product Offered
Table 114. Wuhan Institute of Biological Products Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Wuhan Institute of Biological Products Main Business
Table 116. Wuhan Institute of Biological Products Latest Developments
Table 117. Walvax Biotechnology Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 118. Walvax Biotechnology Pertussis Vaccination Product Offered
Table 119. Walvax Biotechnology Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Walvax Biotechnology Main Business
Table 121. Walvax Biotechnology Latest Developments
Table 122. Chengdu Institute of Biological Products Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 123. Chengdu Institute of Biological Products Pertussis Vaccination Product Offered
Table 124. Chengdu Institute of Biological Products Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Chengdu Institute of Biological Products Main Business
Table 126. Chengdu Institute of Biological Products Latest Developments
Table 127. Minhai Biotechnology Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 128. Minhai Biotechnology Pertussis Vaccination Product Offered
Table 129. Minhai Biotechnology Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Minhai Biotechnology Main Business
Table 131. Minhai Biotechnology Latest Developments
List of Figures
Figure 1. Picture of Pertussis Vaccination
Figure 2. Pertussis Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pertussis Vaccination Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Pertussis Vaccination Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pertussis Vaccination Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Acellular Vaccines
Figure 10. Product Picture of Whole-cell Vaccines
Figure 11. Global Pertussis Vaccination Sales Market Share by Type in 2021
Figure 12. Global Pertussis Vaccination Revenue Market Share by Type (2017-2022)
Figure 13. Pertussis Vaccination Consumed in 12 Months Below
Figure 14. Global Pertussis Vaccination Market: 12 Months Below (2017-2022) & (Units)
Figure 15. Pertussis Vaccination Consumed in 12 Months Above
Figure 16. Global Pertussis Vaccination Market: 12 Months Above (2017-2022) & (Units)
Figure 17. Global Pertussis Vaccination Sales Market Share by Application (2017-2022)
Figure 18. Global Pertussis Vaccination Revenue Market Share by Application in 2021
Figure 19. Pertussis Vaccination Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Pertussis Vaccination Revenue Market Share by Company in 2021
Figure 21. Global Pertussis Vaccination Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Pertussis Vaccination Revenue Market Share by Geographic Region in 2021
Figure 23. Global Pertussis Vaccination Sales Market Share by Region (2017-2022)
Figure 24. Global Pertussis Vaccination Revenue Market Share by Country/Region in 2021
Figure 25. Americas Pertussis Vaccination Sales 2017-2022 (Units)
Figure 26. Americas Pertussis Vaccination Revenue 2017-2022 ($ Millions)
Figure 27. APAC Pertussis Vaccination Sales 2017-2022 (Units)
Figure 28. APAC Pertussis Vaccination Revenue 2017-2022 ($ Millions)
Figure 29. Europe Pertussis Vaccination Sales 2017-2022 (Units)
Figure 30. Europe Pertussis Vaccination Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Pertussis Vaccination Sales 2017-2022 (Units)
Figure 32. Middle East & Africa Pertussis Vaccination Revenue 2017-2022 ($ Millions)
Figure 33. Americas Pertussis Vaccination Sales Market Share by Country in 2021
Figure 34. Americas Pertussis Vaccination Revenue Market Share by Country in 2021
Figure 35. United States Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Pertussis Vaccination Sales Market Share by Region in 2021
Figure 40. APAC Pertussis Vaccination Revenue Market Share by Regions in 2021
Figure 41. China Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Pertussis Vaccination Sales Market Share by Country in 2021
Figure 48. Europe Pertussis Vaccination Revenue Market Share by Country in 2021
Figure 49. Germany Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Pertussis Vaccination Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Pertussis Vaccination Revenue Market Share by Country in 2021
Figure 56. Egypt Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Pertussis Vaccination in 2021
Figure 62. Manufacturing Process Analysis of Pertussis Vaccination
Figure 63. Industry Chain Structure of Pertussis Vaccination
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...